HU9700126D0 - 2-oxo- and 2-thio-1,2-dihydroquinolinyl-oxazotidinone derivatives - Google Patents

2-oxo- and 2-thio-1,2-dihydroquinolinyl-oxazotidinone derivatives

Info

Publication number
HU9700126D0
HU9700126D0 HU9700126A HUP9700126A HU9700126D0 HU 9700126 D0 HU9700126 D0 HU 9700126D0 HU 9700126 A HU9700126 A HU 9700126A HU P9700126 A HUP9700126 A HU P9700126A HU 9700126 D0 HU9700126 D0 HU 9700126D0
Authority
HU
Hungary
Prior art keywords
oxazotidinone
dihydroquinolinyl
thio
oxo
derivatives
Prior art date
Application number
HU9700126A
Other languages
English (en)
Inventor
Stephan Bartel
Rainer Endermann
Walter Guarnieri
Dieter Haebich
Hein-Peter Kroll
Bernd Riedl
Martin Ruppelt
Andreas Stolle
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of HU9700126D0 publication Critical patent/HU9700126D0/hu
Publication of HUP9700126A2 publication Critical patent/HUP9700126A2/hu
Publication of HUP9700126A3 publication Critical patent/HUP9700126A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
HU9700126A 1996-01-16 1997-01-15 2-oxo- and 2-thio-1,2-dihydroquinolinyl-oxazotidinone derivatives and pharmaceutical compositions containing them, process for producing the compounds and intermediates of them HUP9700126A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19601265A DE19601265A1 (de) 1996-01-16 1996-01-16 2-Oxo- und 2-Thio-1,2-dihydrochinolinyl-oxazolidinone

Publications (3)

Publication Number Publication Date
HU9700126D0 true HU9700126D0 (en) 1997-02-28
HUP9700126A2 HUP9700126A2 (hu) 1998-12-28
HUP9700126A3 HUP9700126A3 (en) 1999-05-28

Family

ID=7782816

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9700126A HUP9700126A3 (en) 1996-01-16 1997-01-15 2-oxo- and 2-thio-1,2-dihydroquinolinyl-oxazotidinone derivatives and pharmaceutical compositions containing them, process for producing the compounds and intermediates of them

Country Status (28)

Country Link
US (1) US5861413A (hu)
EP (1) EP0785197A3 (hu)
JP (1) JPH09194478A (hu)
KR (1) KR970059174A (hu)
AR (1) AR005458A1 (hu)
AU (1) AU711924B2 (hu)
BG (1) BG62257B1 (hu)
BR (1) BR9700688A (hu)
CA (1) CA2194945A1 (hu)
CO (1) CO4520188A1 (hu)
CZ (1) CZ12897A3 (hu)
DE (1) DE19601265A1 (hu)
EE (1) EE9700019A (hu)
HN (1) HN1996000124A (hu)
HR (1) HRP960614A2 (hu)
HU (1) HUP9700126A3 (hu)
IL (1) IL119994A0 (hu)
NO (1) NO970174L (hu)
NZ (1) NZ314057A (hu)
PE (1) PE35398A1 (hu)
PL (1) PL317930A1 (hu)
SG (1) SG46764A1 (hu)
SK (1) SK5897A3 (hu)
SV (1) SV1997000002A (hu)
TN (1) TNSN97009A1 (hu)
TR (1) TR199601002A1 (hu)
YU (1) YU1097A (hu)
ZA (1) ZA97302B (hu)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9601666D0 (en) * 1996-01-27 1996-03-27 Zeneca Ltd Chemical compounds
DE19802239A1 (de) * 1998-01-22 1999-07-29 Bayer Ag Neue mit Bicyclen substituierte Oxazolidinone
KR20010015910A (ko) 1998-01-23 2001-02-26 로렌스 티. 마이젠헬더 옥사졸리디논 조합 라이브러리, 조성물 및 제조 방법
EP1082323A2 (en) * 1998-06-05 2001-03-14 AstraZeneca UK Limited Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
US6514529B2 (en) 2000-03-22 2003-02-04 Pharmacia & Upjohn Company Oxazolidinone tablet formulation
MY127336A (en) * 2000-03-22 2006-11-30 Upjohn Co Container for linezolid iv solution
GB0009803D0 (en) * 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
DK1301207T3 (da) 2000-06-30 2005-10-10 Pharmacia & Upjohn Co Llc Sammensætninger til behandling af bakterieinfektioner indeholdende en oxazolidinonforbindelse, sulbactam og ampicillin
EP1349853B1 (en) * 2000-12-21 2006-03-08 Pharmacia & Upjohn Company LLC Antimicrobial quinolone derivatives and use of the same to treat bacterial infections
WO2003031441A1 (en) * 2001-10-04 2003-04-17 Morphochen Aktiengesellschaft Für Kombinatorische Chemie Multiple action compounds
WO2003031443A1 (en) 2001-10-04 2003-04-17 Morphochem Aktiengesellschaft für kombinatorische Chemie Dual actions antibiotics comprising a oxazoldinone and a quinolone or naphthyridinone moiety
US7141588B2 (en) * 2002-02-25 2006-11-28 Pfizer, Inc. N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
AR038536A1 (es) * 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
MXPA05001558A (es) * 2002-08-12 2005-09-08 Pharmacia & Upjohn Co Llc N-aril-2-oxazolidinonas y sus derivados.
AU2002339721A1 (en) * 2002-09-20 2004-04-08 Lupin Limited Oxazolidinone derivatives, process for their preperation and their use as antimycobacterial agents
BR0316483A (pt) * 2002-11-21 2005-10-11 Upjohn Co Derivados de n-(4-(piperazin-1-il)-fenil-2-oxazolidinona-5-carboxami da e compostos relacionados como agentes antibacterianos
EP1567520B1 (en) * 2002-12-04 2008-10-15 Glaxo Group Limited Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents
EP1594865A2 (en) * 2003-02-07 2005-11-16 Warner-Lambert Company LLC Antibacterial agents
JP2006516989A (ja) * 2003-02-07 2006-07-13 ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー 抗菌剤として使用するための二環式環によりｎ−置換されたオキサゾリジノン誘導体
US20040204463A1 (en) * 2003-04-01 2004-10-14 Harris Christina Renee N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
RU2351335C2 (ru) 2003-04-30 2009-04-10 Морфохем Акциенгезельшафт Фюр Комбинаторише Хеми Применение оксазолидинон-хинолиновых гибридных антибиотиков для лечения сибирской язвы и других инфекций
DE10340485B4 (de) 2003-09-03 2015-05-13 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Verfahren zur Herstellung von Oxazolidinon-Chinolon Hybriden
US7304050B2 (en) * 2003-09-16 2007-12-04 Pfizer Inc. Antibacterial agents
SI1709044T2 (sl) 2003-12-18 2014-02-28 Morphochem Aktiengesellschaft Fuer Kombinatorische Chemie Oksazolidinon-kinolonski hibridni antibiotiki
US8158797B2 (en) 2003-12-18 2012-04-17 Morphochem Aktiengesellschaft Fur Kombinatorische Chemie Oxazolidinone-quinolone hybrid antibiotics
US7494578B2 (en) * 2004-03-01 2009-02-24 Atotech Deutschland Gmbh Iron-phosphorus electroplating bath and method
JP2008509126A (ja) * 2004-08-06 2008-03-27 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 抗菌剤としてオキシインドールを含有するオキサゾリジノン類
MY150958A (en) 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
US20100144717A1 (en) * 2006-12-15 2010-06-10 Janelle Comita-Prevoir 2-quinolinone and 2-quinoxalinone-derivatives and their use as antibacterial agents
TW200831517A (en) * 2006-12-15 2008-08-01 Astrazeneca Ab Chemical compounds
AR070458A1 (es) * 2008-02-22 2010-04-07 Actelion Pharmaceuticals Ltd Derivados de oxazolidina, una composicion farmaceutica que los contiene y su uso en la preparacion de un medicamento para el tratamiento de una infeccion bacteriana.
JP2017523213A (ja) * 2014-08-06 2017-08-17 ノバルティス アーゲー 抗菌薬としてのキノロン誘導体
KR20220055171A (ko) * 2020-10-26 2022-05-03 주식회사 아이비스바이오 포말리도마이드로부터 3,6'-디티오포말리도마이드를 선택적으로 합성하는 방법

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4705799A (en) * 1983-06-07 1987-11-10 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl benzenes useful as antibacterial agents
US4965268A (en) * 1987-10-09 1990-10-23 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
US4801600A (en) * 1987-10-09 1989-01-31 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
CA1320730C (en) * 1987-10-16 1993-07-27 The Du Pont Merck Pharmaceutical Company Aminomethyl oxooxazolidinyl aroylbenzene derivatives useful as antibacterial agents
US4942183A (en) * 1987-10-16 1990-07-17 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl aroylbenzene derivatives useful as antibacterial agents
US5254577A (en) * 1988-07-29 1993-10-19 The Du Pont Merck Pharmaceutical Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
US5164510A (en) * 1988-09-15 1992-11-17 The Upjohn Company 5'Indolinyl-5β-amidomethyloxazolidin-2-ones
ATE112773T1 (de) 1988-09-15 1994-10-15 Upjohn Co 5-indolinyl-5-beta-amidomethyloxazolidin-2-one, 3-(substituierte kondensierte)phenyl-5-beta amidomethyloxazolidin-2-one und 3-(nitrogen- substituierte)phenyl-5-beta-amidomethyloxazolid n-2-one.
JP2669579B2 (ja) 1991-10-23 1997-10-29 エーザイ株式会社 オキサゾリドン誘導体
DE4332384A1 (de) * 1993-09-23 1995-03-30 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten III
TW286317B (hu) * 1993-12-13 1996-09-21 Hoffmann La Roche
DE4425612A1 (de) * 1994-07-20 1996-04-04 Bayer Ag 6-gliedrige stickstoffhaltige Heteroaryl-oxazolidinone

Also Published As

Publication number Publication date
MX9700419A (es) 1997-07-31
EP0785197A3 (de) 1999-02-10
BR9700688A (pt) 1998-09-01
YU1097A (sh) 1999-12-27
SK5897A3 (en) 1997-09-10
EE9700019A (et) 1997-08-15
PE35398A1 (es) 1998-08-29
CA2194945A1 (en) 1997-07-17
US5861413A (en) 1999-01-19
DE19601265A1 (de) 1997-07-17
PL317930A1 (en) 1997-07-21
HRP960614A2 (en) 1998-02-28
SG46764A1 (en) 1998-02-20
TNSN97009A1 (fr) 2005-03-15
AU711924B2 (en) 1999-10-21
CO4520188A1 (es) 1997-10-15
EP0785197A2 (de) 1997-07-23
NO970174L (no) 1997-07-17
HUP9700126A3 (en) 1999-05-28
JPH09194478A (ja) 1997-07-29
KR970059174A (ko) 1997-08-12
TR199601002A1 (tr) 1997-08-21
NZ314057A (en) 1998-11-25
CZ12897A3 (en) 1997-08-13
SV1997000002A (es) 1997-08-29
HN1996000124A (es) 1997-06-18
IL119994A0 (en) 1997-04-15
BG101131A (en) 1998-04-30
HUP9700126A2 (hu) 1998-12-28
BG62257B1 (bg) 1999-06-30
ZA97302B (en) 1997-07-17
NO970174D0 (no) 1997-01-15
AU1009797A (en) 1997-07-24
AR005458A1 (es) 1999-06-23

Similar Documents

Publication Publication Date Title
HU9700126D0 (en) 2-oxo- and 2-thio-1,2-dihydroquinolinyl-oxazotidinone derivatives
HK1018216A1 (en) New 19-nor-pregnene derivatives.
HUP9903965A3 (en) Substituted 6,5-hetero-bicyclic derivatives
HK1019597A1 (en) Substituted 6, 6-hetero-bicyclic derivatives
HU9700358D0 (en) New oxazolidinon derivatives
ZA976224B (en) 4-hydroxy-piperidine derivatives.
IL126624A0 (en) 3-descladinose-2, 3-anhydroerythromycin derivatives
HK1018457A1 (en) Alkylaminobenzothiazole and-benzoxazole derivatives.
HUP9701835A2 (hu) Vinil-pirrolidinon-cefalosporin-származékok
ZA974953B (en) Substituted pyrazolylpyrazole derivatives.
ZA982436B (en) Thiazolimine derivatives.
ZA9710653B (en) 4-hydroxy-piperidine derivatives.
GB9604996D0 (en) Benzodiazonine derivatives
ZA971167B (en) Heterocyclyl-ergoline derivatives.
CY2322B1 (en) Benzoaeguequinoline derivatives.
GR3034261T3 (en) 14alpha,17alpha-c2-bridged 19-nor-progesterone derivatives
GB9600063D0 (en) Guaridine derivatives
SG70589A1 (en) 1, 25-Dihydroxy-16, 22, 23-trisdehydro-cholecalciferol derivatives
AU6423298A (en) 4-arylmethylene-1,4-dihydro-2h-azine derivatives
ZA981307B (en) 4-aminoethoxyindazole derivatives.
ZA9710062B (en) Heterocyclic derivatives.
ZA985559B (en) Tetrahydroimidazo Ä2,1-aÜsoquinoline derivatives
ZA972692B (en) Pyrrolopyrrolone derivatives.
ZA977881B (en) N-benzylazolium derivatives.
ZA973409B (en) 3-descladinose-2,3-anhydroerythromycin derivatives.